CAM

Cormorant Asset Management Portfolio holdings

AUM $1.76B
1-Year Est. Return 415.22%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+415.22%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.76B
AUM Growth
-$516M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
71
New
Increased
Reduced
Closed

Top Buys

1
+$76.6M
2
+$64.1M
3
+$39M
4
EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
+$30.8M
5
BEAM icon
Beam Therapeutics
BEAM
+$17.3M

Top Sells

1
+$63.6M
2
+$38.8M
3
+$37.2M
4
ASND icon
Ascendis Pharma
ASND
+$19.5M
5
CRSP icon
CRISPR Therapeutics
CRSP
+$19.1M

Sector Composition

1 Healthcare 93.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$137M 7.78%
3,056,797
-339,853
2
$125M 7.1%
2,100,000
+109,078
3
$85.5M 4.87%
2,950,000
+437,135
4
$81.4M 4.64%
2,025,000
-875,000
5
$74.1M 4.22%
+825,000
6
$70.3M 4.01%
487,206
-329,194
7
$67M 3.82%
1,762,500
+265,000
8
$65.3M 3.72%
850,000
-432,392
9
$64.1M 3.65%
2,040,021
-259,979
10
$60.7M 3.46%
2,266,108
-433,892
11
$60.6M 3.45%
+2,767,078
12
$53.9M 3.07%
1,100,000
+604,308
13
$45.2M 2.58%
1,732,200
+129,824
14
$39.2M 2.23%
1,709,765
-78,878
15
$33.7M 1.92%
2,523,700
+998,700
16
$32.8M 1.87%
700,000
17
$29.8M 1.7%
+620,290
18
$29.8M 1.7%
875,551
-124,449
19
$29.4M 1.68%
500,000
-100,000
20
$28.2M 1.6%
250,000
-150,000
21
$27.6M 1.57%
61,950
-21,383
22
$26.7M 1.52%
630,400
-369,600
23
$26.3M 1.5%
450,000
+105,000
24
$24.8M 1.41%
700,000
25
$23.9M 1.36%
426,104
+269,704
1
2 3